Recruiting

Tumor Analysis

Sponsor:

University of Oklahoma

Code:

NCT06960798

Conditions

Prostate Cancer

Renal Cell Carcinoma (RCC)

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bio-specimen Collection

Blood Draw

Study Details

Brief summary:

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prespecified cancers of interest. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Conditions

Prostate Cancer

Renal Cell Carcinoma (RCC)

Study ID

NCT06960798

Start date

Nov 2, 2026

Status verified date

Oct, 2026

Completion date

Oct 30, 2029

Anticipated

Primary completion date

Oct 30, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
  • At least 18 years-of-age at the time of signature of the informed consent form (ICF).
  • Patients who self-identify as Native American.
  • Patients with a pathologically proven diagnosis of PC and RCC (any stage).
  • Availability of most recent archived tumor samples.

Exclusion Criteria:

  • Patients not of Native American descent or identity.
  • Patient does not have archival tissue available.

Study Design

Enrollment

300 participants

Anticipated

Interventions and Outcome Measures

Arms

Cohort (A) Native American Men with Prostate Cancer

150 patients will be assigned in this cohort

Cohort (B) Native American Patients with Renal Cell Carcinoma

150 patients will be assigned in this cohort

Interventions

Bio-specimen Collection

Tissue samples will be taken from existing archived collections and sent for further analysis.

Blood Draw

Blood samples will be collected within the first year of enrollment.

Primary outcome measure

  • Disease-specific genomic and transcriptomic profiles in Native American patients [ Time Frame: 1-3 years ]

Central Contacts and Locations

Central contacts

Lead Onco Nurse

405-271-8777SCC-IIT-Office@ouhsc.edu

Adanma Ayanambakkam, MD, MS

405-271-4022Adanma-Ayanambakkam@ou.edu

Locations

OU Health Stephenson Cancer Center

Recruiting

Oklahoma City, Oklahoma, United States, 73117

Contacts

Adanma Ayanambakkam, MD

405-271-4022Adanma-Ayanambakkam@ou.edu

More Information

Sponsor

University of Oklahoma

Last update posted

Oct 13, 2026

Last verified

Oct, 2026

Keywords

  • Genomic Profile
  • Native American

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-23. This information was provided to ClinicalTrials.gov by University of Oklahoma on 2026-10-13. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.